As artificial intelligence continues to redefine industries, its most transformative impact in biotech is happening b ...

The startup aims to provide every life sciences expert with their team of intelligent agents, reducing response timelines for ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

The research arm of Fenway Health, a community health center focused on care for the LGBT community, is seeing significant ...

America's Frontier Fund seeks $315 million to invest in national security startups, leveraging private capital and government ...

Discover 14 AI penny stocks with huge potential for growth. Learn about companies disrupting biotech, defense, and more.

Avalo Therapeutics, Inc. (NASDAQ:AVTX) is among the best growth stocks to invest in for the next 5 years. On Monday, the ...

The scheme is aimed at fostering local innovation and reducing reliance on foreign patents. It targets diverse industries, ...

TG Therapeutics, Inc. (NASDAQ: TGTX) is one of the 14 stocks Jim Cramer recently looked at. When a caller inquired about the company during the lightning round, Cramer stated: “I remember when Mike ...

Adelis Equity agreed today to sell its majority stake in Stockholm-headquartered Europa Biosite to EQT Healthcare Growth.

Analytica Lab Africa will be co-located with IFAT Africa at Gallagher Convention Centre in Midrand from 8 to 10 July 2025 ...

Investing.com -- Dianthus Therapeutics (NASDAQ: DNTH) stock rose 5.8% after receiving its 13th buy rating, with William Blair analyst Mylers Minter initiating coverage with an Outperform rating.